Phase 1b/2 Study of IV Sarilumab in Adult With RA

NCT07704580 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Sarilumab, SAR153191 SC
DRUG: Sarilumab, SAR153191 IV

Sponsor

Sanofi

Collaborators

[object Object]